AAAAAA

   
Results: 1-8 |
Results: 8
HGV GBV-C IN LIVER-TISSUE AND IN SERA FROM PATIENTS WITH CHRONIC HEPATITIS-C/
Authors: FABRIS P BIASIN MR INFANTOLINO D ROMANO L BENEDETTI P TOSITTI G PELLIZZER GP ZANETTI AR STECCA C MARCHELLE G DELALLA F
Citation: P. Fabris et al., HGV GBV-C IN LIVER-TISSUE AND IN SERA FROM PATIENTS WITH CHRONIC HEPATITIS-C/, Infection, 26(5), 1998, pp. 283-287
ADAPTIVE RESPONSE TO DNA-DAMAGING AGENTS - A REVIEW OF POTENTIAL MECHANISMS
Authors: STECCA C GERBER GB
Citation: C. Stecca et Gb. Gerber, ADAPTIVE RESPONSE TO DNA-DAMAGING AGENTS - A REVIEW OF POTENTIAL MECHANISMS, Biochemical pharmacology, 55(7), 1998, pp. 941-951
AMPHOTERICIN-B AS PRIMARY THERAPY FOR CRYPTOCOCCOSIS IN PATIENTS WITHAIDS - RELIABILITY OF RELATIVELY HIGH-DOSES OVER A RELATIVELY SHORT-PERIOD - REPLY
Authors: DELALLA F PELLIZZER G VAGLIA A MANFRIN V FRANZETTI M FABRIS P STECCA C
Citation: F. Delalla et al., AMPHOTERICIN-B AS PRIMARY THERAPY FOR CRYPTOCOCCOSIS IN PATIENTS WITHAIDS - RELIABILITY OF RELATIVELY HIGH-DOSES OVER A RELATIVELY SHORT-PERIOD - REPLY, Clinical infectious diseases, 21(5), 1995, pp. 1353-1353
AMPHOTERICIN-B AS PRIMARY THERAPY FOR CRYPTOCOCCOSIS IN PATIENTS WITHAIDS - RELIABILITY OF RELATIVELY HIGH-DOSES ADMINISTERED OVER A RELATIVELY SHORT-PERIOD
Authors: DELALLA F PELLIZZER G VAGLIA A MANFRIN V FRANZETTI M FABRIS P STECCA C
Citation: F. Delalla et al., AMPHOTERICIN-B AS PRIMARY THERAPY FOR CRYPTOCOCCOSIS IN PATIENTS WITHAIDS - RELIABILITY OF RELATIVELY HIGH-DOSES ADMINISTERED OVER A RELATIVELY SHORT-PERIOD, Clinical infectious diseases, 20(2), 1995, pp. 263-266
PREVALENCE OF ANTI-HCV AND RISK-FACTORS FOR HEPATITIS-C VIRUS-INFECTION IN HEALTHY PREGNANT-WOMEN
Authors: MARRANCONI F FABRIS P STECCA C ZAMPIERI L BETTINI MC DIFABRIZIO N DELALLA F
Citation: F. Marranconi et al., PREVALENCE OF ANTI-HCV AND RISK-FACTORS FOR HEPATITIS-C VIRUS-INFECTION IN HEALTHY PREGNANT-WOMEN, Infection, 22(5), 1994, pp. 333-337
ACUTE-PANCREATITIS ASSOCIATED WITH ADMINISTRATION OF MEGLUMINE ANTIMONATE FOR THE TREATMENT OF VISCERAL LEISHMANIASIS
Authors: DELALLA F PELLIZZER G GRADONI L VESPIGNANI M FRANZETTI M STECCA C
Citation: F. Delalla et al., ACUTE-PANCREATITIS ASSOCIATED WITH ADMINISTRATION OF MEGLUMINE ANTIMONATE FOR THE TREATMENT OF VISCERAL LEISHMANIASIS, Clinical infectious diseases, 16(5), 1993, pp. 730-731
REGIONAL AND SYSTEMIC PROPHYLAXIS WITH TEICOPLANIN IN MONOLATERAL ANDBILATERAL TOTAL KNEE REPLACEMENT PROCEDURES - STUDY OF PHARMACOKINETICS AND TISSUE PENETRATION
Authors: DELALLA F NOVELLI A PELLIZZER G MILOCCHI F VIOLA R RIGON A STECCA C DALPIZZOL V FALLANI S PERITI P
Citation: F. Delalla et al., REGIONAL AND SYSTEMIC PROPHYLAXIS WITH TEICOPLANIN IN MONOLATERAL ANDBILATERAL TOTAL KNEE REPLACEMENT PROCEDURES - STUDY OF PHARMACOKINETICS AND TISSUE PENETRATION, Antimicrobial agents and chemotherapy, 37(12), 1993, pp. 2693-2698
METABOLIC-ACTIVATION BY A SUPERNATANT FROM HUMAN HEPATOMA-CELLS - A POSSIBLE ALTERNATIVE IN MUTAGENIC TESTS
Authors: DUVERGERVANBOGAERT M DIERICKX PJ STECCA C CRUTZEN MC
Citation: M. Duvergervanbogaert et al., METABOLIC-ACTIVATION BY A SUPERNATANT FROM HUMAN HEPATOMA-CELLS - A POSSIBLE ALTERNATIVE IN MUTAGENIC TESTS, MUTATION RESEARCH, 292(2), 1993, pp. 199-204
Risultati: 1-8 |